There is momentum within the U.S. Congress to make a difference in the lives of kidney transplant patients. Last week, the full House Committee on Energy and Commerce unanimously passed H.R. 5534, the Comprehensive Drug Coverage for Kidney Transplant Patients Act (referred to as the "Immuno Bill"). This vote was a critical next step toward ensuring that transplant patients can secure the lifesaving immunosuppressive medications they must take to maintain a life-saving transplant.
Senate bill S.3353 and House bill H.R. 5534 are companion bills aimed to improve patients' access to immunosuppressive drugs, helping recipients maintain their transplants and hopefully avoid future kidney-related health care complications. The AST is asking you to help by participating in this new grassroots campaign. Even if you previously reached out to your House and Senate representatives, this legislation continues to advance, and every contact helps to keep it moving.
Contact your Congressional representatives to request support and swift approval of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (S. 3353 and H.R. 5534) during the 116th Congress.
Although the capacity for full access has been reached and the waitlist is closed, you can still register for "limited access" for the Fellows Symposium! There is no fee for limited access and no eligibility requirements that need to be met. Registration for limited access will close on August 26th.
Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients. See the Video
Recently updated, the AST has published FAQ pages and other resources for both professionals and patients.
The updated patient COVID FAQs in English can be found HERE. The updated patient COVID FAQ's in Spanish can be found HERE. The updated Recommendations and Guidance for Organ Donor Testing document can be found HERE. Also, updated FAQs on medication access and Rx shortage can be found HERE.
In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
The 2019-2020 Timely Topics in Transplantation (T3) webinar series is available on-demand! Watch expert faculty present on a variety of important topics in transplantation, including "Advanced Technology in Transplant Care," "Non-invasive Biomarkers for Allograft Rejection," and "HCV NAT+/- in Solid Organ Transplantation."
The COVID‐19 pandemic is a rapidly changing circumstance with dramatic policy changes and universal efforts to deal with the initial crisis and minimize its consequences. To identify changes to organ donation and transplantation during this time, an anonymous web‐based survey was distributed to 19 select organ procurement organizations (OPOs) throughout the US comparing 90‐day activity during March ‐ May 2020 and March – May 2019. 17 OPOs responded to the survey (response rate of 89.5%).
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Standardized discharge criteria are critical to reduce the risk of premature discharge and avoid unnecessary days in hospital. No such criteria exist for patients who have undergone liver transplantation.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
Thousands of meeting planners and other industry professionals subscribe to AST's e-News, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
Heart transplantation from ABO incompatible (ABOi) donors has evolved into a progressively accepted therapy in young children. We assessed the recent practice of ABOi listing impacton waitlist and post-transplant outcomes
In patients with reduced kidney function there are no established guidelines to suggest combined heart-kidney transplant (HKTx) versus sequential kidney transplant (SKTx) using preoperative value of estimated glomerular filtration (eGFR).
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion SARS-CoV-2 spike protein.
